C-MIMI: FDA readies program to speed software reviews

SAN FRANCISCO - The U.S. Food and Drug Administration (FDA) wants to make it...Read more on AuntMinnie.comRelated Reading: Business models emerge for AI in medical imaging Live from C-MIMI: Dr. Bradley Erickson on AI and radiology Live from C-MIMI: Dr. Eliot Siegel on AI and radiology FDA clears Viz.ai's stroke detection software C-MIMI: FDA decision paves the way for imaging AI
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

ConclusionsMore than three retriever passes may increase the rate of recanalization, but not the likelihood of favorable functional outcomes in ischemic stroke patients treated with mechanical thrombectomy. Notably, multiple retriever passes may also increase the risk of intracranial hemorrhage.Evidence-Based MedicineLevel of Evidence: Level 4, Case Series.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
AbstractPurposeIn patients with acute occlusions of the middle cerebral artery, the collaterals play an important role in infarct growth and potentially on clinical outcome. As the primary collateral pathway, the posterior cerebral artery with the posterior communicating artery (PComA) is important. We analyzed the influence of the presence of an ipsilateral PComA on infarct growth and clinical outcome.MethodsWe included 101 patients with M1 occlusions and subsequent endovascular treatment and differentiated patients without an ipsilateral PComA from those with an ipsilateral PComA.ResultsThere was no difference in the rat...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
AbstractPurposeThe aim of this study is to assess the feasibility of aspiration mechanical thrombectomy in patients with massive and submassive pulmonary embolism (PE) and contraindications to thrombolysis.Materials and MethodsEighteen patients presenting massive (8/18) or submassive (10/18) PE were prospectively enrolled between October 2016 and November 2017. All the patients enrolled had contraindications to thrombolysis (haemorrhagic stroken = 1, ischaemic stroke in the preceding 6 monthsn = 7, central nervous system damage or neoplasmsn = 1, recent major trauma/surgery/he...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
Cerebrovasc Dis 2018;46:I
Source: Cerebrovascular Diseases - Category: Neurology Source Type: research
ConclusionPreoperative skin disinfection with IPA–CHG is superior to only IPA, and it should be recommended. The addition of a retrosternal gentamicin-releasing sponge further reduces the rate of mediastinitis.
Source: Journal of Hospital Infection - Category: Infectious Diseases Source Type: research
HeartFlow said yesterday that it won reimbursement coverage from the Japanese Ministry of Health, Labor and Welfare for its HeartFlow FFRct fractional flow reserve analysis. The Redwood City, Calif.-based company said that it has already received approval from the Japanese Pharmaceuticals and Medical Devices Agency, and that reimbursement will go into effect beginning on December 1. “When a patient presents with symptoms suggesting CAD, we want to be able to quickly and effectively diagnose patients while reducing the need for unnecessary tests or invasive procedures. In clinical studies, we were able to see fir...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cardiovascular Featured Imaging Software / IT HeartFlow Source Type: news
Conclusions: The study suggested that a dysfunction of the ipsilesional M1 and abnormal interhemispheric interactions might underlie the motor disability in acute ischemic stroke. Modifying the excitability of the motor cortex and correcting the abnormal motor network connectivity associated with the motor deficit might be the therapeutic target in early neurorehabilitation for stroke patients. PMID: 30420876 [PubMed - in process]
Source: Neural Plasticity - Category: Neurology Authors: Tags: Neural Plast Source Type: research
ConclusionPRR improved neuronal injuries that were induced by transient cerebral ischemia via inhibiting gliosis and elevating antioxidants.
Source: Chinese Herbal Medicines - Category: Complementary Medicine Source Type: research
Condition:   Hemorrhagic Stroke Interventions:   Drug: Brevibloc, 10 Mg/mL Intravenous Solution;   Drug: Nitroprusside, Sodium Sponsor:   Cristália Produtos Químicos Farmacêuticos Ltda. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Independence Stairs Climbing Ability Prediction During the Sub-acute Rehabilitation Phase of People After Stroke Intervention:   Other: Follow up Sponsors:   Sheba Medical Center;   Tel Aviv University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Food and Drug Administration (FDA) | Radiology | Stroke